3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
25
Multiple Myeloma
13
Prostatic Neoplasms
10
Osteoporosis
8
Neoplasm Metastasis
8
Carcinoma, Non-Small-Cell Lung
5
Fractures, Bone
4
Neoplasms, Plasma Cell
3
Lymphoma
3
Bone Diseases, Metabolic
3
Bone Diseases
3
Spinal Cord Compression
2
Pain
2
Ovarian Neoplasms
2
Osteosarcoma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Hematologic Neoplasms
2
Carcinoma, Renal Cell
2
Bone Neoplasms
2
Uterine Cervical Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Pleural Effusion, Malignant
1
Paraproteinemias
1
Oligodendroglioma
1
Neoplastic Processes
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Nasopharyngeal Neoplasms
1
Interventions
Rituximab
4
blinatumomab
3
Whole-Body Irradiation
3
Cyclophosphamide
3
fludarabine phosphate
2
Mycophenolic Acid
2
Melphalan
2
Lenalidomide
2
Clofarabine
2
treosulfan
1
thymoglobulin
1
sabatolimab
1
pembrolizumab
1
peginterferon alfa-2a
1
obinutuzumab
1
midostaurin
1
ixazomib
1
fludarabine
1
eribulin
1
daratumumab
1
acalabrutinib
1
Trastuzumab
1
Tacrolimus
1
Sodium Chloride
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Pentostatin
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Methotrexate
1
Magnetic Resonance Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neoplasm, Residual
×
Zoledronic Acid
×
Clear all
No trials found.